Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience

Pituitary

Volumn 15, Issue 2, 2012, Pages 215-221

  Minuto, Francesco M ^a   Resmini, Eugenia ^a   Boschetti, Mara ^a   Rebora, Alberto ^a   Fazzuoli, Laura ^a   Arvigo, Marica ^a   Giusti, Massimo ^a   Ferone, Diego ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Acromegaly; Growth hormone; IGF I; OGTT

Indexed keywords

GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; FOLLOW UP; GROWTH HORMONE RELEASE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84861455879     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0313-4     Document Type: Article

References (23)

1. Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355:2558-2573
2. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71-79 (Pubitemid 10174985)
3. Bengtsson BA, Eden S, Ernest I, Oden A, Sjogren B (1988) Epidemiology and long-Term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327-335
4. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152 (Pubitemid 38269977)
5. Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2:29-41
6. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674 (Pubitemid 38269875)
7. Strasburger CJ (2005) IGF-I and mortality in patients with acromegaly. J Endocrinol Invest 28:78-80
8. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S (2000) Criteria for cure of acromegaly: A consensus statement. J Clin Endocr Metab 85:526-529 (Pubitemid 32273628)
9. Trainer PJ (2002) Editorial: Acromegaly-consensus, what consensuš J Clin Endocrinol Metab 87:3534-3536
10. Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57:555-559
11. Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A (2004) Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clin Endocrinol (Oxf) 61:138-144 (Pubitemid 38951657)
12. expert committee on the diagnosis, classification of diabetes mellitus (2003) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1): S5-S20
13. Carmichael JD, Bonert VS, Mirocha JM, Melmed S (2009) The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 94:523-527
14. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310 (Pubitemid 16134762)
15. Grottoli S, Razzore P, Gaia D, Gasperi M, Giusti M, Colao A, Ciccarelli E, Gasco V, Martino E, Ghigo E, Camanni F (2003) Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. J Endocrinol Invest 26:123-127 (Pubitemid 36503058)
16. Ribeiro-Oliveira A Jr., Faje AT, Barkan AL (2011) Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol 164:17-22
17. Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, Ghigo E, Ho K, Jaquet P, Kleinberg D, Lamberts S, Laws E, Lombardi G, Sheppard MC, Thorner M, Vance ML, Wass JA, Giustina A (2005) Consensus statement: medical management of acromegaly. Eur J Endocrinol 153:737-740 (Pubitemid 43020222)
18. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: An update. J Clin Endocrinol Metab 94:1509-1517
19. Arafat AM, Mohlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schofl C, Pfeiffer AF (2008) Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 93:1254-1262 (Pubitemid 351519718)
20. Murray RD, Kim K, Ren SG, Chelly M, Umehara Y, Melmed S (2004) Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. J Clin Invest 114:349-356 (Pubitemid 39071607)
21. Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67:69-73
22. Barreca A, Ciccarelli E, Minuto F, Bruzzi P, Giordano G, Camanni F (1989) Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly. Acta Endocrinol Copenh 120:629-635 (Pubitemid 19123896)
23. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202